We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
59 hedge funds and large institutions have $158M invested in Amphastar Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
180% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 10
74% more capital invested
Capital invested by funds: $90.7M → $158M (+$67.4M)
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
7% more funds holding
Funds holding: 55 → 59 (+4)
Holders
59
Holders Change
+4
Holders Change %
+7.27%
% of All Funds
1.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
28
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$17.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.31M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$7.26M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$4.15M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$3.94M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$11.1M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$2.32M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$1.94M |
| 4 |
FCE
Fiera Capital (Europe)
Grand Cayman,
Cayman Islands
|
-$1.51M |
| 5 |
JP Morgan Chase
New York
|
-$1.06M |
